The largest community of pharma leaders


2850 articles

Frank Neumann, M.D., Ph.D., to Depart Verastem Oncology

BOSTON--(BUSINESS WIRE)--Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced the...

Merck Announces U.S. FDA Approval of VERQUVO® (vericiguat)

KENILWORTH, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck Announces U.S. FDA Approval of VERQUVO® (vericiguat) Source Business Wire Health: Pharmaceutical NewsRead More

Applied DNA Promotes Judith Murrah to Chief Operating Officer

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced...

Talaris Therapeutics Adds Two Experienced Biotechnology Executives to its Board of Directors

BOSTON & LOUISVILLE, Ky.--(BUSINESS WIRE)--Talaris Therapeutics, Inc., a privately held biotechnology company developing transformative cell therapies that have the potential to induce durable immune...

Turnstone Biologics Acquires Novel Cell Therapy Platform

NEW YORK--(BUSINESS WIRE)--Acquisition of Myst Therapeutics adds proprietary tumor infiltrating lymphocyte (“TIL”) technology and programs to Turnstone’s growing portfolio Source Read More